16 Ron Baron Moderna Trades
The first Moderna trade was made in Q2 2020. Since then Ron Baron bought shares seven more times and sold shares on eight occasions. The investor completely sold their stake between Q4 2023 and Q1 2024.
Avg closing price
Price range
Sold -7.5 Thousand shares
Q1 2024
Avg closing price
$100.80
Price range
$85.37
-
$115.44
Sold 98.2% shares (-419 Thousand shares)
Q4 2023
Avg closing price
$84.11
Price range
$69.51
-
$104.43
Increased shares by 4863.6% (+418 Thousand shares)
Q3 2023
Avg closing price
$111.55
Price range
$96.41
-
$126.61
Sold 36.3% shares (-4.9 Thousand shares)
Q2 2023
Avg closing price
$133.40
Price range
$118.50
-
$160.53
Sold 55.0% shares (-16.5 Thousand shares)
Q1 2023
Avg closing price
$164.97
Price range
$135.66
-
$197.02
Increased shares by 76.5% (+13 Thousand shares)
Q4 2022
Avg closing price
$163.51
Price range
$118.38
-
$210.04
Increased shares by 45.3% (+5.3 Thousand shares)
Q3 2022
Avg closing price
$151.74
Price range
$118.07
-
$194.18
New holding (+11.7 Thousand shares)
Q2 2022
Avg closing price
$142.94
Price range
$117.13
-
$176.59
Sold -2.53 Thousand shares
Q1 2022
Avg closing price
$168.36
Price range
$126.46
-
$235.05
Sold 94.9% shares (-46.8 Thousand shares)
Q4 2021
Avg closing price
$292.38
Price range
$225.82
-
$368.51
Sold 24.4% shares (-16 Thousand shares)
Q3 2021
Avg closing price
$368.80
Price range
$221.90
-
$484.47
Increased shares by 47.8% (+21.1 Thousand shares)
Q2 2021
Avg closing price
$178.71
Price range
$129.91
-
$234.98
Increased shares by 1062.7% (+40.4 Thousand shares)
Q1 2021
Avg closing price
$144.91
Price range
$109.18
-
$185.98
New holding (+3.8 Thousand shares)
Q4 2020
Avg closing price
$101.17
Price range
$65.74
-
$169.86
Sold -1 Thousand shares
Q3 2020
Avg closing price
$69.72
Price range
$54.34
-
$94.85
New holding (+1 Thousand shares)
Q2 2020
Avg closing price
$54.76
Price range
$29.67
-
$80.00
News about Moderna Inc and Ron Baron
Thacker: Leading Medical Journal Busted With Huge Conflict Of Interest Over ''Medical Misinformation'' Expert
Thacker: Leading Medical Journal Busted With Huge Conflict Of Interest Over ''Medical Misinformation'' Expert A leading medical journal, JAMA, recently publi...
Is Moderna (MRNA) a High Growth Stock?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2022 investor letter. A copy of the same can be downloade...